Cancer Commons puts the patient at the front end of a remarkable experiment in translational medicine — one in which basic molecular biology, computational methods and a network of experts and institutions collaborate to work out personalized medical solutions.

Donald Kennedy, Ph.D. President Emeritus Stanford University and Editor of Science (2000 – 2008)